Biology:Neurogenin-3

From HandWiki
Revision as of 20:20, 11 May 2023 by OrgMain (talk | contribs) (link)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Neurogenin-3 is a protein that in humans is encoded by the NEUROG3 gene.[1]

Neurogenin-3 is expressed in endocrine progenitor cells and is required for endocrine cell development in the pancreas and intestine.[2] It belongs to a family of basic helix-loop-helix (bHLH) transcription factors involved in the determination of neural precursor cells in the neuroectoderm.[3]

Neurogenin 3 (NGN3) is expressed by 2-10% of acinar and duct cells in the histologically normal adult human pancreas. NGN3+ cells isolated from cultured exocrine tissue by coexpressed cell surface glycoprotein CD133 have a transcriptome consistent with exocrine dedifferentiation, a phenotype that resembles endocrine progenitor cells during development, and a capacity for endocrine differentiation in vitro.[4] Human[5] and rodent[6][7][8][9][10][11][12][13][14] exocrine cells have been reprogrammed into cells with an islet cell-like phenotype following direct expression of NGN3 or manipulation that leads to its expression.

Detail

Much more at Neurogenins#Neurogenin-3

References

  1. "Entrez Gene: neurogenin 3". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=50674. 
  2. "Mutant neurogenin-3 in congenital malabsorptive diarrhea". The New England Journal of Medicine 355 (3): 270–80. Jul 2006. doi:10.1056/NEJMoa054288. PMID 16855267. 
  3. "neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas". Proceedings of the National Academy of Sciences of the United States of America 97 (4): 1607–11. Feb 2000. doi:10.1073/pnas.97.4.1607. PMID 10677506. Bibcode2000PNAS...97.1607G. 
  4. "Neurogenin 3 Expressing Cells in the Human Exocrine Pancreas Have the Capacity for Endocrine Cell Fate". PLOS ONE 10 (8): e0133862. 2015. doi:10.1371/journal.pone.0133862. PMID 26288179. Bibcode2015PLoSO..1033862G. 
  5. "Plasticity of adult human pancreatic duct cells by neurogenin3-mediated reprogramming". PLOS ONE 7 (5): e37055. 2012. doi:10.1371/journal.pone.0037055. PMID 22606327. Bibcode2012PLoSO...737055S. 
  6. "Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas". Cell 132 (2): 197–207. Jan 2008. doi:10.1016/j.cell.2007.12.015. PMID 18243096. 
  7. "Neurogenin 3+ cells contribute to β-cell neogenesis and proliferation in injured adult mouse pancreas". Cell Death & Disease 4 (3): e523. 7 March 2013. doi:10.1038/cddis.2013.52. PMID 23470530. 
  8. "Local in vivo GSK3β knockdown promotes pancreatic β cell and acinar cell regeneration in 90% pancreatectomized rat". Molecular Therapy 20 (10): 1944–52. Oct 2012. doi:10.1038/mt.2012.112. PMID 22828498. 
  9. "Activation of pancreatic-duct-derived progenitor cells during pancreas regeneration in adult rats". Journal of Cell Science 123 (Pt 16): 2792–802. Aug 2010. doi:10.1242/jcs.065268. PMID 20663919. 
  10. "Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice". Nature Biotechnology 32 (1): 76–83. Jan 2014. doi:10.1038/nbt.2747. PMID 24240391. 
  11. "Ngn3 expression during postnatal in vitro beta cell neogenesis induced by the JAK/STAT pathway". Cell Death and Differentiation 13 (11): 1892–9. Nov 2006. doi:10.1038/sj.cdd.4401883. PMID 16514419. 
  12. "Reprogramming of human pancreatic exocrine cells to β-like cells". Cell Death and Differentiation 22 (7): 1117–30. Jul 2015. doi:10.1038/cdd.2014.193. PMID 25476775. 
  13. "In vivo reprogramming of adult pancreatic exocrine cells to beta-cells". Nature 455 (7213): 627–32. Oct 2008. doi:10.1038/nature07314. PMID 18754011. Bibcode2008Natur.455..627Z. 
  14. "Loss of Fbw7 reprograms adult pancreatic ductal cells into α, δ, and β cells". Cell Stem Cell 15 (2): 139–53. Aug 2014. doi:10.1016/j.stem.2014.06.019. PMID 25105579. 

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.